Treatments emerging from the digital therapeutics space were once greeted with optimism, due to the potential to aid patients’ health through technology, rather than pharmaceuticals. Ben ...
A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...
Medicover Hospitals will utilise Lupin Digital Health’s advanced Digital Therapeutics (DTx) platform, Lyfe, licensed as a Class C medical device by the regulator CDSCO, to enhance its cardiac ...
The growth of the digital therapeutics market is attributed to the increase in adoption of smartphones and tablets coupled with healthcare applications, growth in need to control healthcare cost, and ...
According to Precedence Research, the global digital therapeutics market size was estimated at USD 7.88 billion in 2024 and is expected to hit around USD 56.76 billion by 2034, poised to grow at a ...
The overarching aim of this PhD studentship is to develop a toolkit for multimodal quantification of motor, cognitive, and lifestyle dimensions of such personalised interventions, and determine the ...
The Europe digital therapeutics market size was valued at $0.50 billion in 2018 and is expected to reach $2.27 billion by 2026 with a CAGR of 20.6% during the forecast period. Digital therapeutics is ...
credit: Getty Images Swamy Venuturupalli, MD, and Beth Darnall, PhD, discuss the emerging field of digital therapeutics and their potential for managing chronic pain in rheumatic disease. Recent ...